Stock Views on Lupin, Godawari Power & Ispat, Crompton Greaves

Emkay Global on Lupin- Target Rs 980

Emkay Global Financial Services has maintained its buy rating on Lupin, with price target of Rs 980, in its report dated.

"Since this is a sub-judice matter, it is difficult to take a call which way the judgment goes? However, by the spirit of the matter taken up by the EU authorities and chronology of events leading to out of court settlement raises an iota of doubt about the intention of settlement between innovator (Servier) and Lupin. At the moment, we can not estimate the exact loss; therefore impact on financials can not be assessed. In worst case scenario, this event will lead to one time charges, which could be as high as Rs 3.7 billion (10% of FY09 revenue). Hence, we continue to maintain our Buy rating with a target of Rs 980," says Emkay Global Financial Services' research report.

Karvy Stock Broking on Godawari Power & Ispat - Target Rs 128

Karvy Stock Broking has recommended a buy rating on Godawari Power & Ispat, with price target of Rs 128, in its report.

"The stock is trading at 0.6x its FY09 & 0.55x its FY10 BV. We revise FY10 earning estimates by 6% on account of change in MAT rate. However, we retain our valuation of 0.8x FY10 BV and target price of Rs 128/share. However, due to recent correction in stock price, we revise our rating from out performer to 'BUY'," says Karvy Stock Broking's report.

Sharekhan on Crompton Greaves - Target Rs 308

Sharekhan has recommended a buy rating on Crompton Greaves, with price target of Rs 308, in its report.

"We like Crompton Greaves for its consistent performance at the operating level. Moreover, its ability to improve its working capital management in a tough environment (most other companies have indicated a stretched working capital cycle) is quite impressive. We reiterate our bullish stance on the company and maintain our Buy recommendation on the stock. At the current market price the stock is discounting its FY2010 and FY2011 earnings estimates by 16.3x and 14.8x respectively, target of Rs 308," says Sharekhan's research report.